Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Singapore S.E.
Equities
T14
CNE100000924
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2 USD | +1.01% | -1.49% | -4.35% |
04-30 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
04-30 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Recommends Dividend | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.19B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B | |
+39.87% | 1.45B |
- Stock Market
- Equities
- 600329 Stock
- T14 Stock
- News Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
- Tianjin Zhong Xin Pharmaceutical : Chinese Medical Firm Takes Controlling Stake in Tianjin Zhongxin Pharmaceutical Shareholder, Launches Takeover Bid